![Leon E. Rosenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leon E. Rosenberg
Presidente presso
Talon Therapeutics, Inc.
Profilo
Leon E.
Rosenberg is currently the Non-Executive Chairman at Talon Therapeutics, Inc., Adjunct Professor at Yale University, and Professor at Princeton University.
He previously held positions as Chairman at Karo Healthcare AB, Director at Email Real Estate.com, Inc., Director at Lovelace Respiratory Research Institute, and Director at MMV Medicines for Malaria Venture.
He was also the Senior Vice President-Scientific Affairs at Bristol Myers Squibb Co. from 1997 to 1998 and the President at Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997.
Rosenberg received his undergraduate and doctorate degrees from the University of Wisconsin.
Posizioni attive di Leon E. Rosenberg
| Società | Posizione | Inizio |
|---|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Presidente | 01/02/2004 |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/1997 |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 27/04/2011 |
Precedenti posizioni note di Leon E. Rosenberg
| Società | Posizione | Fine |
|---|---|---|
Email Real Estate.com, Inc.
 Email Real Estate.com, Inc. Financial ConglomeratesFinance Development stage company | Direttore/Membro del Consiglio | 13/10/2004 |
| BRISTOL-MYERS SQUIBB COMPANY | Direttore Tecnico/Scientifico/R&S | 01/03/1998 |
Bristol-Myers Squibb Pharmaceutical Research Institute | Presidente | 01/01/1997 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Direttore/Membro del Consiglio | - |
Lovelace Respiratory Research Institute
 Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Direttore/Membro del Consiglio | - |
Formazione di Leon E. Rosenberg
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Email Real Estate.com, Inc.
Email Real Estate.com, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Karo Healthcare AB
 Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Commercial Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
Bristol-Myers Squibb Pharmaceutical Research Institute |
